Area of research
Critical Care and Intensive Care Medicine · Developmental Neuroscience
Research interest
Research focused on Neuropathic pain and Obeticholic acid, with related work in Rifaximin, Transplantation, Hepatocellular carcinoma. Notable publications include '<p>The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease</p>', 'Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis', and 'Microencapsulated Schwann cell transplantation inhibits P2X2/3 receptors overexpression in a sciatic nerve injury rat model with neuropathic pain'.
An Electroencephalography Profile of Paroxysmal Kinesigenic Dyskinesia
Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition)
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis
<p>The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease</p>
Microencapsulated Schwann cell transplantation inhibits P2X2/3 receptors overexpression in a sciatic nerve injury rat model with neuropathic pain
Microencapsulated Schwann cell transplantation inhibits P2X3 receptor expression in dorsal root ganglia and neuropathic pain
Effect of combined mutations in the enhancer <scp>II</scp> and basal core promoter of hepatitis <scp>B</scp> virus on development of hepatocellular carcinoma in <scp>Q</scp>idong, <scp>C</scp>hina